Developer docs
API playgroundTry for free, no card

Search company profiles

CYTOCELL LIMITED

Full company profile

uuid004896s

Namestring
CYTOCELL LIMITED
Legal namestring
Oxford Gene Technology IP Limited
Websiteurl
cytocell.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

CytoCell Limited, operating under the legal entity Oxford Gene Technology IP Limited, is a privately held UK molecular cytogenetics company headquartered in Cambridge with a 2000 founding date and 13 reported employees. Its flagship offering is a fluorescence in situ hybridisation (FISH) probe portfolio of over 545 ready-to-order products spanning haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications, plus a custom probe design service branded myProbes. The FISH probes are sold either as Research Use Only (RUO) products or as IVDR-certified probes for diagnostic use in Europe, supported by laboratory accessories (tissue pretreatment kits, microscope filters, hybridisation chambers, buffers) and an integrated imaging/analysis partnership with Applied Spectral Imaging (ASI). The portfolio extends beyond FISH into SureSeq next-generation sequencing and CytoSure aCGH microarray sub-brands, positioning the company across multiple cytogenetics and genomics modalities.

The business model centres on one-time/perpetual licence sales of FISH probes and accessories with pay-as-you-go billing, supplemented by multi-year contracts for custom probe development through the myProbes service. Pricing is not publicly disclosed; customers engage via direct consultative sales (phone and email) with contact routed through the parent OGT infrastructure. Go-to-market is enterprise field sales targeting research laboratories, hospitals, and genetics centres globally, with dedicated regional websites for the UK, USA, and Canada markets. Customer evidence includes NHS hospitals, US academic medical centres, government institutes, and commercial genetics laboratories across the UK, USA, Canada, and Serbia, with several relationships spanning two decades. The company also operates a DNA Dispatch newsletter, online product documentation portal, and customer testimonial-driven content marketing channel.

Short descriptiontext

CytoCell Limited, a UK molecular cytogenetics brand of Oxford Gene Technology, sells over 545 FISH probes and custom probe services for clinical and research laboratories in haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
Markets served

Serves global market

Keyword5 values
FISH probe manufacturing, cytogenetic diagnostics, molecular cytogenetics, DNA probe design, custom FISH probes
Industry3 codes
PRIMARYHLAGANAJ
Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Cytogenetic Diagnostics Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1FISH Probes and Accessories Sales
TypeOne Time License
Description

Sale of ready-to-order IVDD and RUO FISH probes along with supporting accessories including tissue pretreatment kits, microscope filters, hybridisation chambers, and buffers

ogt.com
2Custom FISH Probe Development
TypeOne Time License
Description

myProbes customisation service for developing bespoke FISH probes tailored to specific laboratory requirements

ogt.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others
Pricing details3 tiers
1Research Use Only (RUO) FISH probes
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Products labeled For Research Use Only; Not for Use in Diagnostic Procedures

ogt.com
2IVDR-certified FISH probes
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Regulatory-compliant products for diagnostic use in applicable regions

ogt.com
3Custom FISH probe development (myProbes)
ModelOtherBilling cadenceMulti-year contract
Notes

Custom development service with pricing based on project specifications

ogt.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1CytoCell
Description

World-leading fluorescence in situ hybridisation (FISH) probes product portfolio including over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications.

ogt.com
+3 more records
Core offering1 text field

CytoCell Limited, operating under Oxford Gene Technology (OGT), manufactures and sells a comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes used by clinical cytogenetics laboratories to detect genetic abnormalities in haematological malignancies, solid tumours, constitutional cytogenetics, and rare diseases. Offerings span ready-to-order IVDD/RUO and IVDR-certified probes, the myProbes custom FISH probe design service, complementary FISH laboratory accessories, as well as OGT's adjacent SureSeq NGS and CytoSure aCGH microarray product lines.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 545 ready-to-order IVDD and RUO FISH probes available
+3 more records
Product overview1 text field

CytoCell Limited, operating under Oxford Gene Technology (OGT), offers a comprehensive molecular diagnostics portfolio comprising FISH probes as its core product line alongside complementary NGS (SureSeq) and aCGH microarray (CytoSure) platforms. The CytoCell FISH portfolio represents the primary offering with over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications, supported by IVDR-certified probes, custom probe design services (myProbes), FISH imaging and analysis solutions, and laboratory accessories. The SureSeq NGS and CytoSure Arrays brands extend the portfolio into next-generation sequencing and microarray-based genomic analysis.

Product and service2 records
1CytoCell FISH Probes
CategoryCore product
Description

Comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes covering haematology, solid tumour, cytogenetics, and rare disease applications, with IVDD/RUO and IVDR-certified variants. Designed for clinical cytogenetics laboratories, hospitals, and genetics centres.

2CytoCell IVDR-Certified FISH Probes
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers1 record
1Abbott Molecular
TypeBroad incumbent
Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights1 record

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CYTOCELL LIMITED

Cytogenetic Diagnostics Reagentscytocell.com

CytoCell Limited, a UK molecular cytogenetics brand of Oxford Gene Technology, sells over 545 FISH probes and custom probe services for clinical and research laboratories in haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications.

What CYTOCELL LIMITED does

CytoCell Limited, operating under the legal entity Oxford Gene Technology IP Limited, is a privately held UK molecular cytogenetics company headquartered in Cambridge with a 2000 founding date and 13 reported employees. Its flagship offering is a fluorescence in situ hybridisation (FISH) probe portfolio of over 545 ready-to-order products spanning haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications, plus a custom probe design service branded myProbes. The FISH probes are sold either as Research Use Only (RUO) products or as IVDR-certified probes for diagnostic use in Europe, supported by laboratory accessories (tissue pretreatment kits, microscope filters, hybridisation chambers, buffers) and an integrated imaging/analysis partnership with Applied Spectral Imaging (ASI). The portfolio extends beyond FISH into SureSeq next-generation sequencing and CytoSure aCGH microarray sub-brands, positioning the company across multiple cytogenetics and genomics modalities.

The business model centres on one-time/perpetual licence sales of FISH probes and accessories with pay-as-you-go billing, supplemented by multi-year contracts for custom probe development through the myProbes service. Pricing is not publicly disclosed; customers engage via direct consultative sales (phone and email) with contact routed through the parent OGT infrastructure. Go-to-market is enterprise field sales targeting research laboratories, hospitals, and genetics centres globally, with dedicated regional websites for the UK, USA, and Canada markets. Customer evidence includes NHS hospitals, US academic medical centres, government institutes, and commercial genetics laboratories across the UK, USA, Canada, and Serbia, with several relationships spanning two decades. The company also operates a DNA Dispatch newsletter, online product documentation portal, and customer testimonial-driven content marketing channel.

CYTOCELL LIMITED firmographics

Firmographics
Name
CYTOCELL LIMITED
Legal name
Oxford Gene Technology IP Limited
Website
https://cytocell.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
CytoCell Limited, a UK molecular cytogenetics brand of Oxford Gene Technology, sells over 545 FISH probes and custom probe services for clinical and research laboratories in haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications.
Ownership category
akta.pro rank

CYTOCELL LIMITED industry classification

Industry
Product category
Cytogenetic Diagnostics Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGANAJ
Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • FISH probe manufacturing
  • Cytogenetic diagnostics
  • Molecular cytogenetics
  • DNA probe design
  • Custom FISH probes

CYTOCELL LIMITED business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. FISH Probes and Accessories Sales: Sale of ready-to-order IVDD and RUO FISH probes along with supporting accessories including tissue pretreatment kits, microscope filters, hybridisation chambers, and buffers
  2. Custom FISH Probe Development: myProbes customisation service for developing bespoke FISH probes tailored to specific laboratory requirements

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goResearch Use Only (RUO) FISH probes
One time/ perpetual licensePay-as-you-goIVDR-certified FISH probes
OtherMulti-year contractCustom FISH probe development (myProbes)

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

CYTOCELL LIMITED product offering

Product offering

Core offering

CytoCell Limited, operating under Oxford Gene Technology (OGT), manufactures and sells a comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes used by clinical cytogenetics laboratories to detect genetic abnormalities in haematological malignancies, solid tumours, constitutional cytogenetics, and rare diseases. Offerings span ready-to-order IVDD/RUO and IVDR-certified probes, the myProbes custom FISH probe design service, complementary FISH laboratory accessories, as well as OGT's adjacent SureSeq NGS and CytoSure aCGH microarray product lines.

Product overview

CytoCell Limited, operating under Oxford Gene Technology (OGT), offers a comprehensive molecular diagnostics portfolio comprising FISH probes as its core product line alongside complementary NGS (SureSeq) and aCGH microarray (CytoSure) platforms. The CytoCell FISH portfolio represents the primary offering with over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications, supported by IVDR-certified probes, custom probe design services (myProbes), FISH imaging and analysis solutions, and laboratory accessories. The SureSeq NGS and CytoSure Arrays brands extend the portfolio into next-generation sequencing and microarray-based genomic analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • CytoCell: World-leading fluorescence in situ hybridisation (FISH) probes product portfolio including over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications.
  • CytoSure
  • SureSeq
  • myProbes

Products and services

  • CytoCell FISH Probes Comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes covering haematology, solid tumour, cytogenetics, and rare disease applications, with IVDD/RUO and IVDR-certified variants. Designed for clinical cytogenetics laboratories, hospitals, and genetics centres.
  • CytoCell IVDR-Certified FISH Probes

Quantifiable outcome

  • Over 545 ready-to-order IVDD and RUO FISH probes available
  • +3 more outcomes

Companies that use CYTOCELL LIMITED

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

CYTOCELL LIMITED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

CYTOCELL LIMITED partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

CYTOCELL LIMITED competitors and assessment

Company assessment

Broad incumbents

  • Abbott Molecular:

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights1 record

Customer concentration

CYTOCELL LIMITED social profiles

Digital presence

CYTOCELL LIMITED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CYTOCELL LIMITED leadership team

Management profile

Number of profiles

CYTOCELL LIMITED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CYTOCELL LIMITED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CYTOCELL LIMITED

What does CYTOCELL LIMITED do?

CytoCell Limited, operating under Oxford Gene Technology (OGT), manufactures and sells a comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes used by clinical cytogenetics laboratories to detect genetic abnormalities in haematological malignancies, solid tumours, constitutional cytogenetics, and rare diseases. Offerings span ready-to-order IVDD/RUO and IVDR-certified probes, the myProbes custom FISH probe design service, complementary FISH laboratory accessories, as well as OGT's adjacent SureSeq NGS and CytoSure aCGH microarray product lines.

Is CYTOCELL LIMITED a public or private company?

CYTOCELL LIMITED is a private company. It is classified as unknown and is currently operating.

When was CYTOCELL LIMITED founded?

CYTOCELL LIMITED was founded in 2000. It employs 11 to 50 people.

How does CYTOCELL LIMITED make money?

Two revenue lines are on record. FISH Probes and Accessories Sales are the primary driver. The others are custom FISH Probe Development.

Who are CYTOCELL LIMITED's main competitors?

Abbott Molecular is listed as a broad incumbent.

Does CYTOCELL LIMITED have an API?

No public API is recorded for CYTOCELL LIMITED.

What industry is CYTOCELL LIMITED in?

CYTOCELL LIMITED's product category is Cytogenetic Diagnostics Reagents. Its primary akta.pro industry code is HLAGANAJ, Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV), with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals